EP4001304 - BROADLY NEUTRALIZING ANTIBODY AND USES THEREOF [Right-click to bookmark this link] | Status | Examination is in progress Status updated on 07.06.2024 Database last updated on 08.10.2024 | |
Former | Request for examination was made Status updated on 25.11.2022 | ||
Former | The application has been published Status updated on 22.04.2022 | Most recent event Tooltip | 08.10.2024 | New entry: Reply to examination report | Applicant(s) | For all designated states International Aids Vaccine Initiative 125 Broad Street, 9th Floor New York, NY 10004 / US | For all designated states Cornell University 395 Pine Tree Road Ithaca, NY 14850 / US | For all designated states The Scripps Research Institute 10550 North Torrey Pines Road La Jolla, CA 92037 / US | [2024/30] |
Former [2022/21] | For all designated states International Aids Vaccine Initiative 125 Broad Street, 9th Floor New York, NY 10004 / US | ||
For all designated states Cornell University 395 Pine Tree Road Ithaca, NY 14850 / US | |||
For all designated states The Scripps Research Institute 10550 North Torrey Pines Road La Jolla, CA 92037 / US | Inventor(s) | 01 /
BURTON, Dennis R. La Jolla, CA 92037 / US | 02 /
VAN GILS, J. Marit 1065AE Amsterdam / NL | 03 /
KOFF, Wayne New York, NY 10004 / US | 04 /
POIGNARD, Pascal Raymond Georges New York, NY 10004 / US | 05 /
SANDERS, Rogier W. Ithaca, NY 14850 / US | 06 /
SIMEK-LEMOS, D.J.S. Melissa New York, NY 10004 / US | [2022/21] | Representative(s) | Schüssler, Andrea Kanzlei Huber & Schüssler Truderinger Strasse 246 81825 München / DE | [2022/21] | Application number, filing date | 21207691.3 | 10.06.2015 | [2022/21] | Priority number, date | US201462010852P | 11.06.2014 Original published format: US 201462010852 P | US201462074963P | 04.11.2014 Original published format: US 201462074963 P | [2022/21] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP4001304 | Date: | 25.05.2022 | Language: | EN | [2022/21] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 18.03.2022 | Classification | IPC: | C07K16/10 | [2022/21] | CPC: |
C07K16/1063 (EP,US);
C07K2317/21 (EP,US);
C07K2317/55 (EP,US);
C07K2317/565 (EP,US);
C07K2317/76 (EP,US)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2022/52] |
Former [2022/21] | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR | Title | German: | BREIT NEUTRALISIERENDE ANTIKÖRPER UND VERWENDUNGEN DAVON | [2022/21] | English: | BROADLY NEUTRALIZING ANTIBODY AND USES THEREOF | [2022/21] | French: | ANTICORPS LARGEMENT NEUTRALISANT ET LEURS UTILISATIONS | [2022/21] | Examination procedure | 24.11.2022 | Amendment by applicant (claims and/or description) | 24.11.2022 | Examination requested [2022/52] | 24.11.2022 | Date on which the examining division has become responsible | 06.06.2024 | Despatch of a communication from the examining division (Time limit: M04) | 07.10.2024 | Reply to a communication from the examining division | Parent application(s) Tooltip | EP15001720.0 / EP2975053 | EP18167464.9 / EP3438127 | Fees paid | Renewal fee | 14.01.2022 | Renewal fee patent year 03 | 14.01.2022 | Renewal fee patent year 04 | 14.01.2022 | Renewal fee patent year 05 | 14.01.2022 | Renewal fee patent year 06 | 14.01.2022 | Renewal fee patent year 07 | 30.06.2022 | Renewal fee patent year 08 | 30.06.2023 | Renewal fee patent year 09 | 30.06.2024 | Renewal fee patent year 10 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [A]WO2010107939 (THERACLONE SCIENCES INC [US], et al); | [A]WO2011092593 (INST RESEARCH IN BIOMEDICINE [CH], et al); | [A]WO2012030904 (THERACLONE SCIENCES INC [US], et al); | [A]WO2012040562 (INT AIDS VACCINE INITIATIVE [US], et al); | [A]WO2012154311 (UNIV DUKE [US], et al); | [A]WO2014063059 (UNIV ROCKEFELLER [US]); | by applicant | US4689338 | US5057540 | US5238944 | WO9620013 | US5650398 | WO0147955 | WO0195919 | US6524584 | WO03063899 | US6645495 | US6693086 | WO2004US37699 |